Form 4: Evolent Health Director Acquires Shares

Evolent Health Director Kim Keck acquired 41,096 shares of Class A Common Stock through a restricted stock unit grant.

Summary

• Kim Keck, a Director at Evolent Health, Inc., acquired 41,096 shares of Class A Common Stock on June 4, 2026.
• This acquisition was made through restricted stock units granted under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
• The securities vest on June 4, 2027, or the date of the Company's 2027 annual meeting, contingent upon continued service.
• Following the transaction, Keck beneficially owns 102,597 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard stock grant to a director as part of their compensation and does not indicate a significant change in the company's financial performance or strategic direction.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition is part of a long-term incentive plan, aligning management interests with shareholders.

Risks

• Vesting of the acquired shares is contingent upon continued service, meaning a departure before the vesting date would result in forfeiture.
• The value of the acquired shares is subject to market fluctuations until vested and potentially sold.

Future Outlook

The future outlook for the acquired shares depends on the company's performance and market conditions, with vesting scheduled for June 4, 2027, or the 2027 annual meeting.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly by directors, are common within the healthcare technology sector as a method to retain and incentivize key personnel.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but the actual impact on share price is minimal in the short term.
• Employees: The incentive plan under which the shares were granted highlights the company's approach to employee compensation and retention.
• Management: Reinforces the alignment of director compensation with company performance and long-term value creation.

Next Steps

• Ms. Keck's continued service through the vesting date.
• Potential sale of vested shares by Ms. Keck after the vesting date.

Key Dates

Keywords

Evolent Health, Form 4, Insider Trading, Stock Acquisition, Restricted Stock Units, Kim Keck, Class A Common Stock, Beneficial Ownership